NCT03810664View on ClinicalTrials.gov

A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

April 19, 2019

Study Completion Date

April 19, 2019

Conditions
Healthy Male Volunteers
Interventions
DRUG

Somatrogon

A single dose of 12 mg of somatrogon will be injected as one sc injection to the arm on each dosing day (Day 0 and Day 14).

Trial Locations (1)

33143

QPS Miami Research Associates, Miami

All Listed Sponsors
lead

OPKO Health, Inc.

INDUSTRY

NCT03810664 - A Clinical Study Investigating the Comparability of Somatrogon in Two Different Drug Product Presentations | Biotech Hunter | Biotech Hunter